One-Stop Services: | CRO & CDMO | Technology Brokerage  Licensed Co-Development Partnership 中文 | English
HOME ABOUT US SERVICES RESOURCES MEDIA CENTRE CLIENTS & PARTNERS CONTACT US
Home » Services » China pharmaceutical EU market analysis and strategic business development
 
Services
Europe Technology Transfer & Licence
EU and China R&D Collaboration Project management
Europe and China pre-clinical research management
EU and China Clinical study management and local regulatory affairs
Strategic sourcing and contract manufacturing
China pharmaceutical EU market analysis and strategic business development
China novel drug EU clinical study project management
Chinese pharmaceutical company EU market analysis and strategic business development
Fully Integrated Preclinical CRO Services
UK HQ ADDRESS
Link China Solutions Ltd
Milton Hall
Ely Road, Cambridge
CB24 6WZ
United Kingdom
Phone: 0044(0)1223 828 215
Email: info@chinapharma.co.uk
 

We will help Chinese pharmaceutical companies’ generic drug, novel drug, and biological drug companies define EU market potential by identifying market position and market capability of providing the quickest returns. We will help you assess EU market attractiveness and establish EU market entry priorities according to the economic and socio-political factors affecting EU healthcare market, local regulatory requirements, distribution channels, partner selection and competition. With in-depth research, we will be able to develop, recommend and implement EU healthcare market entry strategies to meet client’s objectives.

Our services are specialised in:
  • Market Opportunity Assessment and Market research
  • Market Entry Strategy
  • Strategy Business Development
      > Partnership selection and evolution
      > Distributor and channel management

 
HOME ABOUT US SERVICES PARTNERSHIP CONTACT US
Copyright © 2011 Link China Solutions Ltd. All rights reserved.